Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -78.67 | N/A |
| PEG Ratio (TTM) | -8.81 | N/A |
| P/S Ratio (TTM) | 5.41 | N/A |
| P/B Ratio (TTM) | 11.63 | N/A |
| P/FCF Ratio (TTM) | 28.88 | N/A |
| Price to 5YR AVG Earnings Ratio | -58.08 | N/A |
| Price to 5YR AVG FCF Ratio | 66.66 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.66% | N/A |
| ROE (TTM) | -16.24% | N/A |
| Net Profit Margin (TTM) | -6.82% | N/A |
| ROIC 5YR AVG | -21.04% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.57% | 26.43% | 1.74% |
| Revenue | 3.04% | 26.57% | 24.57% |
| Net Income | 7.49% | 4.31% | -13.91% |
| Cash Flow | 14.43% | 142.88% | 95.69% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.28 | N/A |
| Quick Ratio (TTM) | 1.28 | N/A |
| D/E Ratio (TTM) | 0.88 | N/A |
| Interest Coverage (TTM) | -0.55 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.22 | N/A |
| LTL to 5YR AVG FCF | 5.72 | N/A |
| Shares Outstanding Growth 5YR AVG | 19.60% | N/A |